F. Allan Hubbell

Picture of F. Allan Hubbell
Professor Emeritus, Medicine
School of Medicine
B.A., Baylor University, 1971, Biology
M.D., Baylor College of Medicine, 1974
M.S.P.H., Univeristy of California, Los Angeles, School of Public Health, 1983
University of California, Irvine

,
Research Interests
Health disparities, cancer prevention and control, women's health and access to medical care
Academic Distinctions
Academic Appointments:

2012-present: Professor Emeritus; Medicine, Public Health and Nursing Science
University of California, Irvine, California

2010-2012: Executive Vice Dean, School of Medicine
University of California, Irvine, California

2008-2012: Senior Associate Dean for Academic Affairs, School of Medicine
University of California, Irvine, California

1997-2012: Professor of Medicine
University of California, Irvine, California

2010-2012: Professor of Nursing Science (Joint Appointment)
University of California, Irvine, California

2007-2012: Professor of Public Health (Joint Appointment)
University of California, Irvine, California

2001-2012: Senior Research Scientist, Health Policy Research Institute
University of California, Irvine, California

2001-2008: Chair, Department of Medicine
University of California, Irvine, California

1992-2001: Director, Center for Health Policy Research
Chief, Division of General Internal Medicine and Primary Care
University of California, Irvine, California

1989-97: Associate Professor of Medicine
University of California, Irvine, California

1981-89: Assistant Professor of Medicine
University of California, Irvine, California

1979-81: Assistant Chief of Medicine for Education
V.A. Medical Center, Long Beach, California
Assistant Clinical Professor of Medicine
University of California, Irvine

Honors:

2002-12: America’s Top Physicians

2009: Outstanding Community Service Award, Society of General
Internal Medicine

2005: Governor’s Guahan (Guam) Award for outstanding contributions to
the island of Guam

2005: Honorary Matai (Chief) for contributions to improving cancer
control for Tongans, American Samoans, and Chamorros

2004: Community Health Research Leadership Award, Center to Reduce
Cancer Health Disparities, National Cancer Institute

1996-2012: Who's Who in America, Who's Who in Medicine and Health Care,
Who’s Who in California, and Who’s Who in the West

1997: Certificate of Recognition for contributions to the American
Samoan Community, City of Carson, California

1991: Certificate of Recognition for Outstanding Teaching, Primary
Care Internal Medicine Residency,University of California,
Irvine

1989: Teacher of the Year Award, Primary Care Clerkship, University
of California, Irvine

1987: Faculty of the Year Award for Excellence in Clinical Teaching,
Department of Medicine, University of California, Irvine

1985: Certificate of Appreciation for work in cost containment, V.A.
Medical Center, Long Beach, California

1983: Outstanding Faculty Member, College of Medicine, University of
California, Irvine

1974: Moody C. Bettis Award for Excellence in Community Medicine,
Baylor College of Medicine

1971-74: Hamilton Fish Scholarship, Baylor College of Medicine
Research Abstract
Dr. Hubbell’s research focuses on the cancer prevention and control needs of medically under-served populations and health policy options to address those needs. Through this research, he is contributing to the national goal of eliminating cancer related health disparities among different ethnic and socioeconomic groups in this country. Examples of the research include NCI-funded studies of cancer–related knowledge, attitudes, and preventive practices among Latinos and Pacific Islanders – special populations that reside in large numbers in southern California. These studies have documented many culturally based beliefs about the risk factors, signs, and symptoms of cancer as well as low use of cancer prevention services. To address cancer control problems, Dr. Hubbell’s research team has developed culturally sensitive cancer prevention programs to improve knowledge about cancer and to increase screening in these populations. Dr. Hubbell is also the Principal Investigator for the Irvine Clinical Center of the Women’s Health Initiative (WHI) sponsored by the NHLBI. The WHI is a large multi-center clinical trial that is evaluating the impact of hormone therapy, calcium/vitamin D, and diet on a variety of cardiovascular, cancer, and musculoskeletal outcomes. Early findings from the study indicated that the risks of long term use of a combination of estrogen and progestin outweighed the benefits. These findings have already changed the way physicians treat postmenopausal women. Because of his expertise, Dr. Hubbell has served on advisory committees for organizations such as the Southwest Oncology Group, the Department of Health and Human Services, Health Resources and Services Administration, the National Board of Medical Examiners, the National Cancer Institute, and the American Cancer Society.
Publications
2000-Present (full publication list available upon request)
Mishra SI, Luce-Aoelua P, Hubbell FA. Knowledge and attitudes about cancer among American Samoans. Cancer Detection and Prevention 2000;24:186-95.
Scherger JE, Rucker L, Cygan RW, Morrison EH, Hubbell FA. The primary care specialties working together: a model of success in an academic environment. Academic Medicine 2000;73:693-8.
Mishra SI, Luce-Aoelua P, Hubbell FA. Predictors of the use of Papanicolaou smears among American Samoan women. Journal of General Internal Medicine 2001;16:320-4.
Mishra SI, Luce-Aoelua P, Hubbell FA. Breast cancer screening in American Samoan women. Preventive Medicine 2001;33:9-17.
Chavez LR, McMullin JM, Mishra SI, Hubbell FA. Beliefs matter: cultural beliefs and the use of cervical cancer screening tests. American Anthropologist 2001;103:1-16.
Morrison EH, Hollingshead J, Wilkerson L, Hubbell FA, Hithcock M, Prislin M. Reach out and teach someone; generalist residents’ needs for teaching skills development. Family Medicine 2002;34:445-50.
Brewster WR, Anton-Culver H, Ziogas A, Largent J, Howe S, Hubbell FA, Manetta A. Recruitment strategies for cervical cancer prevention study. Gynecologic Oncology 2002;85:250-4.
Antman K, Abraido-Lanza AF, Blum D, Brownfield E, Cicatelli B, Debor MD, Emmons K, Fitzgibbon M, Gapstur SM, Gradishar W, Hiatt RA, Hubbell FA, Joe AK, Klassen AC, Lee NC, Linden HM, McMullin J, Mishra SI, Neuhaus C, Olopade FI, Walas K. Reducing disparities in breast cancer survival: a Columbia University and Avon Breast Cancer Research and Care Network Symposium. Breast Cancer Research and Treatment 2002;75:269-80.
Writing Group for the Women’s Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women’s Health Initiative randomized controlled trial. Journal of the American Medical Association 2002;288:321-33.
Hubbell FA, Mishra SI, Luce-Aoelua P. The Pacific Islander Cancer Control Network’s role in cancer awareness, research, and training. Asian American and Pacific Islander Journal of Health 2003;10:41-50.
Morrison EH, Rucker L, Boker JR, Hollingshead J, Hitchcock MA, Prislin MD, Hubbell FA. A pilot randomized controlled trial of a longitudinal residents-as-teachers curriculum. Academic Medicine, 2003;78:1-8.
Hayes J, Hunt JR, Hubbell FA, Anderson GL, Limacher M, Allen, Rossouw JE. The Women’s Health Initiative recruitment methods and results. Annals of Epidemiology 2003;13:18-77.
Chlebowski R, Wactawski-Wende J, Ritenbaugh C, Hubbell FA; Ascensao J, Rodbough RJ, Rosenberg C, Taylor VM, Harris R, Chen C, Adams-Campbell L, White E. Estrogen plus progestin and colorectal cancer in postmenopausal women. New England Journal of Medicine 2004;350:991-1004.
The Women’s Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. Journal of the American Medical Association 2004;291:1701-12.
Hubbell FA, Luce PH, Afeaki WP, Cruz LA, Gumataotao T, McMullin JM, Pouesi J, Reyes ML, Taumoepeau LT, Tu’ufuli GM, Wenzel L. Addressing the cancer control needs of Pacific Islanders: experience of the Pacific Islander Cancer Control Network. Pacific Health Dialog 2004;11:233-8.
Women’s Health Initiative Study Group. Dietary adherence in the Women’s Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association 2004;104:654-658.
Morrison DH, Rucker L, Boker JR, Gabbert CC, Hubbell FA, Hitchcock MA, Prislin MD. The effect of a 13-hour curriculum to improve resident’s teaching skills: a randomized trial. Annals of Internal Medicine 2004;141:257-63.
DeAlba I, Sweningson JM, Chandy C, Hubbell FA. Impact of English language proficiency on receipt of Pap smears among Hispanics. Journal of General Internal Medicine 2004;19:967-70.
McMullin JM, DeAlba I, Chavez LR; Hubbell FA. Influence of beliefs about cervical cancer etiology on Pap smear use among Latina immigrants. Ethnicity and Disease 2005;10:3-18.
DeAlba I, Hubbell FA, McMullin JM, Sweningson JM, Saitz R. Impact of US citizenship status on cancer screening among immigrant women. Journal of General Internal Medicine 2005; 20:290-6.
DeAlba I, Ngo-Metzger Q, Sweningson JM, Hubbell FA. Cervical cancer screening in California: are we closing the racial/ethnic gap? Preventive Medicine 2005;40:747-55.
Chlebowski R, Chen Z, Anderson G, Rohan T, Aragaki A, Lane D, Dolan N, Paskett E, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R. Ethnicity and breast cancer: factors influencing incidence and outcomes. Journal of the National Cancer Institute 2005; 97:439-48.
Hubbell FA, Luce PH, McMullin JM. Exploring beliefs about cancer among American Samoans: focus group findings. Cancer Detection and Prevention 2005;29:109-15.
Anderson GL, Chlebowski RT, Rossouw J, Rodabough R, McTiernan A, Margolis K, Aggerwal A, Curb JD, Hendrix S, Hubbell FA, Khandekar J, Lane D, Lasser N, Lopez AM, Potter J, Ritenbaugh C. Prior hormone therapy and breast cancer risk in the Women’s Health Initiative randomized trial of estrogen plus progestin. Maturitas 2006:55;103-15.
Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL , O’Sullivan MJ, Margolis KL, Ockene JK, Pottern L, Prentice RL, Phillips L, Robbins J, Rohan T, Sarto GE, Sharma S, Stefanick ML, Van Horn L, Wallace R, Whitlock E, Bassford T, Beresford SAA, Black HR, Bonds D, Byzyski RG, Caan B, Cauley JA, Chlebowski RT, Garland C, Cochrand B, Gass M, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Jackson RD, Johnson KC, Judd H, Kooperberg CL, Kuller LH, LaCroix AZ, Lane DS, Langer RD, Lasser NL, Lewis CE, Limacher MC, Manson JE. Calcium and vitamin D supplementation and the risk of colorectal cancer. New England Journal of Medicine 2006;354:684-96.
Gold R, Whitlock E, Michaels Y, Aickin M, Cheryl Ritenbaugh C, Hubbell FA, Safford M, Rodriguez B, Mason ED, Sarto D. Race/ethnicity, socioeconomic status, and lifetime morbidity burden in the Women’s Health Initiative: a cross-sectional analysis. Journal of Women’s Health 2006;15:1161-1173.
Hubbell FA, Luce PH, Afeaki WP, Cruz LA, Mummert A, McMullin JM, Pouesi J, Reyes ML, Taumoepeau LT, Tu’ufuli GM, Wenzel L. Legacy of the Pacific Islander Cancer Control Network. Cancer 2006;107(S):2091-98.
Stefanick ML, Anderson GL, Margolis KL, Hendrix SL, Rodabough RJ, Paskett E, Lane DS, Hubbell FA, Assaf AR, Sarto G, Schenken R, Yasmeen S, Lessin L, Chlebowski RT. Effects of conjugated equine estrogens on breast cancer and mammography in postmenopausal women with hysterectomy: The Women’s Health Initiative Randomized Trial. Journal of the American Medical Association 2006;295:1647-57.
Beresford SAA, Johnson KC, Ritenbaugh C, Lasser N, Snetselaar LG, Black HR, Anderson GL, Assaf A, Bassford T, Vitolins M, Brunner R, Brzyski R, Caan B, Chelbowski R, Gass M, Harrigan R, Hays J, Heiss G, Hendrix S, Howard B, Hsia J, Hubbell FA, Jackson R, Judd H, Kotchen JM, Kuller L, Lane D, Langer R, Lewis C, Manson J, Margolis K, Mossavar-Rahmani Y, Ockene JK, Parker L, Perri M, Phillips L, Prentice RL, Robbins J, Rossouw J, Sarto G, Stefanick M, Van Horn L, Wactawski-Wende J, Wallace R, Vitolins M, Whitlock E. Low-fat dietary pattern and risk of colorectal cancer: the Women’s Health Initiative randomized dietary modification trial. Journal of the American Medical Association 2006;295:643-54.
Howard BV, van Horn L; Hsia J; Manson J, Stefanick ML, Wassertheil-Smoller S, Kuller L, Langer RD, Lasser N, Lewis CE; Limacher M, Margolis K, Mysiw WJ, Ockene J, Parker L, Perri M, Phillips L; Robbins J, Sarto GE, Schatz I, Snetselaar L, Stevens V, Tinker L, Trevisan M, Vitolins M; Assaf AR, Bassford T, Beresford S, Black H, Brunner R, Brzyski R, Caan B, Chlebowski R, Gass M, Granek I, Greenland P, Hays J, Heiss G, Hendrix S, Hubbell FA, Johnson KC, Judd H, Kotchen JM. Low-fat dietary pattern and risk of cardiovascular disease: the Women’s Health Initiative randomized dietary modification trial. Journal of the American Medical Association 2006;295:655-66.
Prentice RL, Caan B, Chlebowski R, Patterson R, Kuller L, Ockene JK, Margolis K, Limacher M, Manson J, Parker L, Paskett E, Phillips L, Robbins J, Rossouw J, Sarto GE, Shikany J, Stefanick ML, Thomson C, Van Horn L, Vitolins M, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S, Whitlock E, Yano K, Adams-Campbell L, Anderson GL, Assaf AR, Beresford SAA, Black H, Brunner R, Byzyski R, Ford L, Gass M, Hays J, Heiss G, Hendrix S, Hsia J, Hubbell FA, Jackson R, Johnson KC, Judd H, Kotchen JM, LaCroix AZ, Lane D, Langer RD, Lasser N, Henerson M. Low-fat dietary pattern and risk of invasive breast cancer: the Women’s Health Initiative randomized dietary modification trial. Journal of the American Medical Association 2006;295:629-42.
Yasmeen S, Romano PS, Pettinger M, Johnson SR, Hubbell FA, McIntosh M, Lane DS, Hendrix SL. Incidence of cytological abnormalities on cervical cancer cytology with aging in the Women’s Health Initiative estrogen plus progestin trial. Obstetrics and Gynecology 2006:108;410-19.
Jackson R, LaCroix AZ, Gass M, Wallace R, Robbins J, Lewis C, Bassford T, Beresford SAA, Black HR, Blanchette P, Bonds D, Brunner RL , Byzyski RG, Caan B, Cauley JA, Chlebowski RT, Cummings S, Granek I, Hays J, Heiss G, Hendrix SL, Hsia J, Hubbell FA, Howard BV, Johnson KC, Judd H, McGowan J, Kotchen JM, Kuller LH, Langer RD, Lasser NL, Limacher MC, Ludlam S, Manson JE, Margolis KL, O’Sullivan MJ, Ockene JK, Phillips L, Prentice RL, Sarto GE, Stefanick ML, Van Horn L, Wactawski-Wende J, Whitlock E, Anderson GL, Assaf AR, Barad D. Calcium plus vitamin D supplementation and the risk for fractures. New England Journal of Medicine 2006;354:669-83.
Chlebowski RT, Anderson GL, Lane DS, Aragaki A, Rohan T, Yasmeen S, Sato G, Rosenberg CA, Hubbell FA. Predicting risk of breast cancer in postmenopausal women by hormone receptor status. Journal of the National Cancer Institute 2007; 99:1695-705.
Prentice RL, Thomson CA, Caan B, Hubbell FA, Anderson GL, Beresford SAA, Lane DS, Lessin L, Yasmeen S, Singh B, Khanderkar J, Shikany JM, Satterfield S, Chlebowski RT. Low-fat dietary pattern and invasive cancer incidence: further results from the Women’s Health Initiative dietary modification trial. Journal of the National Cancer Institute 2007;99:1534-43.
Cui Y, Page DL, Chlebowski RT, Hsia J, Hubbell FA, Johnson K, Rohan TE. Cigarette smoking and risk of benign proliferative epithelial disorders of the breast in the Women’s Health Initiative. Cancer Causes and Control 2007;18:431-8.
Cruz ALH, Chung W, Huh J, Blas L, Cruz LAC, Hubbell FA, Wenzel L. Breast cancer screening among Chamorro women in California. Cancer Detection and Prevention 2008;32(S):16-22.
Puaina S, Aga D, Pouesi D, Hubbell FA. Impact of traditional Samoan lifestyle (fa’aSamoa) on cancer screening practices. Cancer Detection and Prevention 2008;32(S):23-28.
Prentice RL, Chlebowski RT, Stefanick ML, Manson J, Langer R, Pettinger M, Hendrix S, Hubbell FA, Kooperberg C, Kuller L, Lane D, McTiernan A, O’Sullivan MJ, Anderson GL. Conjugated equine estrogens and breast cancer risk in the Women’s Health Initiative Clinical Trial and Observational Study. American Journal of Epidemiology 2008;167:1407-15.
Chlebowski RT, Anderson G, Pettinger M, Lane D, Langer RD, Gillian MA, Walsh BW, Chen C, McTiernan A; Women's Health Initiative Investigators. Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy. Archives of Internal Medicine 2008;168:370-7.
McMullin JM, Taumoepeau L, Talakai M, Kivalu F, Hubbell FA. Tongan perceptions of cancer. Cancer Detection and Prevention 2008;32(S):29-36.
DeAlba I, Anton-Culver H, Hubbell FA, Zioga A, Hess JR, Arias C, Bracho A, Manetta A. Self sampling of human papillomavirus in a community setting: feasibility among Hispanic women. Cancer, Epidemiology, Biomarkers and Prevention 2008;17:2163-8.
Chlebowski RT, Johnson KC, Kooperberg C, Pettinger M, Wactawski-Wende J, Rohan T, Rossouw J, Lane D, O’Sullivan MJ, Yasmeen S, Hiatt RA, Shikany JM, Vitolins M, Khandekar J, Hubbell FA, the Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of breast cancer. Journal of the National Cancer Institute 2008;100:1581-91.
Chu KC, Hubbell FA. Reducing cancer health disparities: perspective of the National Cancer Institute. Cancer Detection and Prevention 2008; 32(S):1-3.
Balajadia R, Wenzel L, Huh J, Sweningson J, Hubbell FA. Cancer-related knowledge, attitudes, and behaviors among Chamorros on Guam. Cancer Detection and Prevention 2008; 32(S):4-15.
Caan BJ, Aragaki A, Thomson CA, Stefanick ML, Chlebowski R, Hubbell FA, Tinker L, Vitolin M, Rajkovic A, Bueche M, Ockene J. Vasomotor symptoms, adoption of a low-fat dietary pattern and risk of invasive breast cancer: a secondary analysis of the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. Journal of Clinical Oncology 2009;27:4500-7.
Chlebowski RT, Schwartz A, Wakelee H, Anderson GL, Stefanick ML, Manson JE, Rodabough R, Chien JW, Wactawski-Wende J, Gass M, Kotchen JM, Ockene J, O'Sullivan MJ Johnson K, Chen C, Hubbell FA. Oestrogen plus progestin and lung cancer in postmenopausal women (Women’s Health Initiative Trial) a post-hoc analysis of a randomised controlled trial. Lancet 2009;374:1243-51.
Prentice RL, Pettinger M, Beresford SAA, Wactawski-Wende J, Hubbell FA, Stefanick ML, Chlebowski RT. Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women’s Health Initiative Clinical Trial and Observational Study. Cancer Epidemiology, Biomarkers and Prevention 2009;18:1531-7.
Michaud DS, Vrieling A, Jiao L, Mendelsohn JB, Steplowski E, Lynch SM, Wactawski-Wende J, Arslan A, Bueno-de-Mesquita HB, Fuchs CS, Buring J, Gaziano M, Gross M, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Allen N, Ammundadottir L, Baofetta P, Bergman MM, Canzian F, Chanock S, Clavel-Chapelon F, Clipp S, Freiberg MS, Hankinson S, Hartge P, Hoover R, Hubbell FA, Hunter D, Jacobs K, Kraft P, Kooperberg C, Manjer J, Navarro, Peeters PHM, Shu XO, Stevens V, Thomas G, Tjønneland A, Tobias G, Trichopoulos D, Tumino R, Vineis P, Virtamo J, Wallace R, Willett W, Wolpin B, Yu K, Zeleniuch-Jacquotte A, Stolzenberg-Solomon RZ. Alcohol intake and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PANSCAN). Cancer Causes and Control. 2010;21(8):1213-25.
Chlebowski RT, Anderson GL, Manson JE, Schwartz A, Wakelee H, Gass M, Rodabough R, Johnson K, Wactawski-Wende J, Kotchen JM, Ockene J, O'Sullivan MJ, Hubbell FA, Chien JW, Chen C, Stefanick ML. Lung cancer among postmenopausal women treated with estrogen alone in the Women’s Health Initiative randomized trial. Journal of the National Cancer Institute. 2010;102(18):1413-21.
Chlebowski R, Anderson G, Manson JE, Pettinger M, Yasmeen S, Lane D, Langer RD, Hubbell FA, McTiernan A, Hendrix S, Schenken R, Stefanick ML. Estrogen alone and breast cancer detection with mammography and breast biopsy. Journal of Clinical Oncology 2010;28(16):2690-7.
Perez LA, Natividad L, Chung W, Wenzel L, Hubbell FA. Social support for Chamorro breast cancer survivors on Guam. California Journal of Health Promotion. 2010;8:63-72.
Chlebowski RT, Johnson KC, Lane D, Pettinger M, Kooperberg CL, Wactawski-Wende J, Rohan T, O’Sullivan MJ, Yasmeen S, Hiatti RA, Shikany JM, Vitolins M, Khandekar J, and Hubbell FA. 25-Hydroxyvitamin D concentration, vitamin D intake and joint symptoms in postmenopausal women. Maturitas. 2011;68(1):73-8.
Farhat GN, Cummings SR, Chlebowski RT, Parimi N, Cauley JA, Rohan TE, Huang AJ, Vitolins M, Hubbell FA, Manson JE, Lee JS. Sex hormones and risk of estrogen receptor-negative and estrogen receptor-positive breast cancer. Journal of the National Cancer Institute. 2011;103(7):562-70.
Simon MS, Thompson CA, Pettijohn E, Kato I, Rodabaugh R, Lane D, Hubbell FA, O’Sullivan MJ, Adams-Campbell LL, Mouton CP, Abrams A, Chleblowski RT. Racial differences in colorectal cancer incidence and mortality in the Women’s Health Initiative. Cancer Epidemiology Biomarkers and Prevention. 2011;20(7):1368-78.
Banegas MP, Gail MH, LaCroix A, Thompson B, Martinez ME, Wactawski-Wende J, John EM, Hubbell FA, Yasmeen S, Katki HA. Evaluating breast cancer risk projections for Hispanic women. Breast Cancer Research and Treatment. 2012 Feb;132(1):347-53.
Anderson GL, Chlebowski RT, Aragaki AK, Kuller LH, Manson JE, Gass M, Bluhm E, Connelly S, Hubbell FA, Lane, D, Martin L, Ockene J, Rohan T, Schenken R, Wactawski-Wende J. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women’s Health Initiative randomised placebo-controlled trial. Lancet Oncology. 2012;13(5):476-86.
Simon MS, Chlebowski RT, Wactawski-Wende J, Johnson KC , Muskovitz A, Kato I, Young A, Hubbell FA, Prentice RL. Estrogen plus progestin and colorectal cancer Incidence and mortality. Journal of Clinical Oncology. 2012;30(32):3983-90.
Livaudais JC, LaCroix AZ, Chlebowski RT, LI CI, Habel LA, Simon MS, Thompson B, Erwin DO, Hubbell FA, Coronado GD. Racial difference in use and duration of adjuvant hormonal therapy for breast cancer in the Women's Health Initiative. Cancer Epidemiology, Biomarkers, and Prevention. 2013;22(3):365-73.
Brunner R, Stefanick ML, Aragaki AK, Beresford SAA, Hubbell FA, LaCroix A, Lane D, Rapp SR, Safford MM, Saquib N, Watts NB, Woods NF. Self-rated health and medical outcomes in the Women’s Health Initiative: the aging continuum, health, morbidity, mortality. Journal of Gerontology and Geriatric Research. 2013 3;139.
Simon MS, Wassertheil-Smoller S, Thomson CA, Ray RN, Hubbell FA, Lessin L, Lane DS, Kuller LH. Mammography interval and breast cancer mortality in women over the age of 75. Breast Cancer Research and Treatment. 2014; 148 (1) 187-95.
Schwartz AG, Ray RM, Cote ML, Abrams J, Sokol RJ, Hendrix SL, Chen C, Chlebowski RT, Hubbell FA, Kooperberg C, Manson JE, O'Sullivan MJ, Rohan T, Stefanick ML, Wactawski-Wende J, Wakelee H, Simon MS. Hormone Use, Reproductive History, and Risk of Lung Cancer: The Women's Health Initiative Studies. Journal of Thorac Oncology. 2015;10:1004-13.
Lavasani S, Chlebowski RT, Prentice RL, Kato I, Wactawski-Wende J, Johnson KC, Young A, Rodabough R, Hubbell FA, Mahinbakht A, Simon MS. Estrogen and colorectal cancer incidence and mortality. Cancer. 2015;121:3261-71.
Grants
2000-Present (full grant list available upon request)
Principal Investigator (Subcontract); Cancer Control Needs among Native American Samoans (U01 CA64434); National Office of Samoan Affairs/ National Cancer Institute; Total direct costs - $481,727; October 1994 - September 2000
Co-Investigator; Medical Education for the 21st Century; PacifiCare Health Systems Corporation; Total direct costs - $769,628; July 1997 - June 2000
Co-Investigator; Samoans and Breast Cancer: Evaluating a Theory Based Program (4BB-1401); University of California Breast Cancer Research Program; Total direct costs - $153,955; July 1998 - June 2001
Principal Investigator (Subcontract); Myocardial Ischemia and Migraine Study: Ancillary Study Women’s Health Initiative; Maryland Medical Research Institute/National Heart, Lung, and Blood Institute; Total direct costs - $59,845; July 1998 – June 2001
Principal Investigator; Access to Public Health Insurance among Urban American Indians in California; Tomas Rivera Policy Institute; Total direct costs - $204,000; April 2000 – March 2002
Principal Investigator; Addressing Survey Implementation Issues among Urban American Indians; The California Endowment; Total direct costs - $201,976; February 2000 – January 2002
Co-Principal Investigator; University of California Irvine Cancer Center Support Grant Supplement: Innovative Cancer Control Initiatives in Cancer Centers (P30 CA62203); National Cancer Institute; Total direct costs - $300,000; March 1999 - February 2002
Co-Investigator; UCI/UCSD Cancer Genetics Network (U24 CA78134); National Cancer Institute; Total direct costs - $2,221,219; March 1998 - February 2004
Co-Investigator; Latina Cervical Cancer Survivorship: A Developmental Study (R21 CA97191); National Cancer Institute;Total direct costs $200,000; July 2002 – June 2004
Principal Investigator (Subcontract); Women’s Health Initiative-Sight Examination (Subcontract); University of Michigan/National Heart, Lung, and Blood Institute Amount: Total direct costs - $177,860; July 2000 – June 2006
Principal Investigator; Pacific Islander Cancer Control Network (U01 CA86073); National Cancer Institute; Total direct costs - $3,021,857; April 2000 – March 2007
Principal Investigator (Subcontract); Women’s Health Initiative Memory Study of Younger Women; Wake Forest University School of Medicine/National Heart, Lung, and Blood Institute; Total direct costs - $3,072 Dates: August 2008 – June 2010
Principal Investigator (Subcontract); Women’s Health Initiative Memory Study Examining the Relationship between Hormone Replacement Therapy and Cognitive Function; Wake Forest University School of Medicine/National Heart, Lung, and Blood Institute; Total direct costs - $4,171; August 2008 – June 2011
Principal Investigator (Subcontract); Women’s Health Initiative Memory Study; Wake Forest University School of Medicine/National Heart, Lung, and Blood Institute; Women’s Health Initiative Memory Study; Total direct costs - $179,112; June 1996 – June 2011
Principal Investigator; Women’s Health Initiative: Clinical Center for the Clinical Trial and Observational Study (N01 WH 4-2107); National Heart, Lung, and Blood Institute; Total direct costs - $10,354,815; October 1994 - September 2010
Principal Investigator; CSUF and UCI-CFCCC Partnership for Cancer Health Disparities Research (P20 CA174188); National Cancer Institute; Total direct costs – $388,347; September 2012 - August 2017
Professional Societies
Society of General Internal Medicine
American Public Health Association
American College of Physicians
Research Centers
Senior Research Scientist, Health Policy Research Institute
Last updated
01/31/2023